Nadine Khoury, María Ángeles Martínez, Stephanie K Nishi, Miguel Ángel Martínez-González, Dolores Corella, Olga Castañer, J Alfredo Martínez, Ángel M Alonso-Gómez, Julia Wärnberg, Jesús Vioque, Dora Romaguera, José López-Miranda, Ramon Estruch, Francisco J Tinahones, José Manuel Santos-Lozano, Lluís Serra-Majem, Aurora Bueno-Cavanillas, Josep A Tur, Sergio Cinza Sanjurjo, Xavier Pintó, José Juan Gaforio, Pilar Matía-Martín, Josep Vidal, Clotilde Vázquez, Lidia Daimiel, Emilio Ros, Carmen Sayon-Orea, Jose V Sorli, Karla-Alejandra Pérez-Vega, Antonio Garcia-Rios, Francisco Ortiz-Díaz, Enrique Gómez-Gracia, M A Zulet, Alice Chaplin, Rosa Casas, Inmaculada Salcedo-Bellido, Lucas Tojal-Sierra, Maria-Rosa Bernal-Lopez, Zenaida Vazquez-Ruiz, Eva M Asensio, Albert Goday, Patricia J Peña-Orihuela, Antonio J Signes-Pastor, Ana Garcia-Arellano, Montse Fitó, Nancy Babio, Jordi Salas-Salvadó
BACKGROUND: Endocrine disruptors (EDs) have emerged as potential contributors to the development of type-2 diabetes. Perfluorooctane sulfonate (PFOS), is one of these EDs linked with chronic diseases and gathered attention due to its widespread in food. OBJECTIVE: To assess at baseline and after 1-year of follow-up associations between estimated dietary intake (DI) of PFOS, and glucose homeostasis parameters and body-mass-index (BMI) in a senior population of 4600 non-diabetic participants from the PREDIMED-plus study...
March 15, 2024: Environment International